Search research articles
Contact Us
Filters
Showing results (171-180 of 210) with videos related to
Page
of 21
Sort By:
Diabetes Care
|
May 1, 1983
Diabetes mellitus and cerebrovascular disease: prevalence of carotid artery occlusive disease and associated risk factors in 482 adult diabetic patients
T W Kuebler, P J Bendick, S E Fineberg, et al.
Alzheimer Disease and Associated Disorders
|
January 1, 1991
Ratings of personality change in patients being evaluated for memory disorders
I C Siegler, K A Welsh, D V Dawson, et al.
Dementia and Geriatric Cognitive Disorders
|
May 15, 2001
Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease
R S Doody, J K Dunn, C M Clark, et al.
Annals of Neurology
|
October 1, 1995
Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease
H Arai, M Terajima, M Miura, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
September 1, 1996
Sherpa brain glucose metabolism and defense adaptations against chronic hypoxia
P W Hochachka, C M Clark, C Monge, et al.
Neurology
|
July 1, 1997
The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD Study. Consortium to Establish a Registry for Alzheimer's Disease
C M Clark, D Ewbank, A Lerner, et al.
Journal of Geriatric Psychiatry and Neurology
|
October 1, 1996
Clinical evaluation of global change in Alzheimer's disease: identifying consensus
J T Olin, L S Schneider, R S Doody, et al.
Diabetes Care
|
November 28, 2001
Incorporating the results of diabetes research into clinical practice: celebrating 25 years of diabetes research and training center translation research
C M Clark, M H Chin, S N Davis, et al.
Alzheimer Disease and Associated Disorders
|
September 15, 1999
Clinical trials in Alzheimer disease: debate on the use of placebo controls
C H Kawas, C M Clark, M R Farlow, et al.
Biochemical and Biophysical Research Communications
|
July 18, 1997
Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology
H Arai, Y Morikawa, M Higuchi, et al.
Page
of 21
Search research articles
Search
Showing results (171-180 of 210) with videos related to
Sort By:
Page
of 21
Diabetes Care
|
May 1, 1983
Diabetes mellitus and cerebrovascular disease: prevalence of carotid artery occlusive disease and associated risk factors in 482 adult diabetic patients
T W Kuebler, P J Bendick, S E Fineberg, et al.
Alzheimer Disease and Associated Disorders
|
January 1, 1991
Ratings of personality change in patients being evaluated for memory disorders
I C Siegler, K A Welsh, D V Dawson, et al.
Dementia and Geriatric Cognitive Disorders
|
May 15, 2001
Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease
R S Doody, J K Dunn, C M Clark, et al.
Annals of Neurology
|
October 1, 1995
Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease
H Arai, M Terajima, M Miura, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
September 1, 1996
Sherpa brain glucose metabolism and defense adaptations against chronic hypoxia
P W Hochachka, C M Clark, C Monge, et al.
Neurology
|
July 1, 1997
The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD Study. Consortium to Establish a Registry for Alzheimer's Disease
C M Clark, D Ewbank, A Lerner, et al.
Journal of Geriatric Psychiatry and Neurology
|
October 1, 1996
Clinical evaluation of global change in Alzheimer's disease: identifying consensus
J T Olin, L S Schneider, R S Doody, et al.
Diabetes Care
|
November 28, 2001
Incorporating the results of diabetes research into clinical practice: celebrating 25 years of diabetes research and training center translation research
C M Clark, M H Chin, S N Davis, et al.
Alzheimer Disease and Associated Disorders
|
September 15, 1999
Clinical trials in Alzheimer disease: debate on the use of placebo controls
C H Kawas, C M Clark, M R Farlow, et al.
Biochemical and Biophysical Research Communications
|
July 18, 1997
Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology
H Arai, Y Morikawa, M Higuchi, et al.
Page
of 21